A quantitation method for mass spectrometry imaging
Stormy L. Koeniger(Abbott (United Kingdom)), Stephen G. Spanton(Abbott Fund), Jennifer B. Bouska(Abbott Fund), Terese Seifert(Abbott Fund), Wayne R. Buck(Abbott Fund), Robert W. Johnson(Abbott Fund), Damien B. Ready(Marquette University), Jane A. Fagerland(Abbott Fund), Martin J. Voorbach(AbbVie (United States)), Yanping Luo(Abbott Fund), Nari Talaty(Abbott Fund)
Cited by 92
Related Papers
ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models
|Clinical Cancer Research|2007|776
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity
|Regulatory Toxicology and Pharmacology|2006|461
Validation of Diacyl Glycerolacyltransferase I as a Novel Target for the Treatment of Obesity and Dyslipidemia Using a Potent and Selective Small Molecule Inhibitor
|Journal of Medicinal Chemistry|2008|140
An Ultraefficient Affinity-Based High-Throughout Screening Process: Application to Bacterial Cell Wall Biosynthesis Enzyme MurF
|SLAS DISCOVERY|2006|73
Discovery of novel inhibitors of Bcl-xL using multiple high-throughput screening platforms
|Analytical Biochemistry|2004|71